We report the results of treatment of 9 patients with advanced multipl
e myeloma (MM) using half-body irradiation. Six nonresponders to chemo
therapy received it as consolidation therapy after the plateau phase o
f MM had been observed, and 4 patients received it as salvage therapy
of refractory or relapsing MM. One of the patients received it twice,
first as consolidation and later during the course of her disease also
as salvage therapy. Objective response was obtained in 1 of 6 patient
s who received half-body irradiation as consolidation therapy and in 3
of 4 patients who received it as salvage therapy. Responders to half-
body irradiation generally achieved a longer relapse-free interval. Tr
eatment with half-body irradiation was especially effective in combina
tion with human leukocyte interferon as salvage therapy in 2 of the pa
tients with refractory MM, leading to a relapse-free interval of more
than 27 months in one of them, Symptomatic relief was observed in 5 of
6 patients. All had transient post-irradiation pancytopenia, with pne
umonitis, nausea and vomiting observed in those who had the upper half
of the body irradiated first. It is thus our opinion that halfbody ir
radiation should not be used as consolidation therapy in nonresponders
to chemotherapy, because it causes undue toxicity to heavily pretreat
ed patients, Its role in the treatment of refractory or relapsing MM i
n combination with human leukocyte interferon should be fully evaluate
d.